Oak Ridge Associated Universities, Oak Ridge, Tennessee, USA.
San Diego State University-University of California, San Diego, Joint Doctoral Program in Public Health, San Diego, California, USA.
LGBT Health. 2021 Apr;8(3):181-189. doi: 10.1089/lgbt.2020.0367. Epub 2021 Feb 9.
We assessed the association of receipt of medical gender affirmation services (e.g., hormones, surgery) with HIV and other sexually transmitted disease (STD) prevention and knowledge indicators among transgender youth. A United States online sample of sexually experienced transgender youth ages 13-24 years ( = 1029) in 2018 completed a cross-sectional survey, including questions about sociodemographics, medical gender affirmation, and HIV and STD prevention outcomes (HIV testing, STD testing, pre-exposure prophylaxis [PrEP] awareness, and nonoccupational postexposure prophylaxis [nPEP] awareness). Logistic regression models were fit to assess the association of medical gender affirmation with HIV and STD prevention outcomes. Interaction terms and stratified models assessed differences in the association between medical gender affirmation and outcomes by gender identity. Participants' mean age was 19.1 (standard deviation = 2.7), 45% were transgender female, 29% transgender male, 26% nonbinary, 53% were youth of color, and 19% accessed medical gender affirmation services. Medical gender affirmation was associated with increased odds of STD testing (adjusted odds ratio [aOR] = 1.90; 95% confidence interval [CI] = 1.33-2.73) with no significant interactions by gender identity. Associations between medical gender affirmation and awareness of PrEP and nPEP varied by gender identity. Among transgender male youth, medical gender affirmation was associated with awareness of PrEP (aOR = 2.65; 95% CI = 1.50-4.71) and nPEP (aOR = 2.03; 95% CI = 1.12-3.71). Among nonbinary youth, medical gender affirmation was associated with awareness of PrEP (aOR = 3.47; 95% CI = 1.26-11.27). Medical gender affirmation was associated with uptake and awareness of sexual health services. Bolstering medical gender affirmation for transgender youth may also bolster preventive health services broadly.
我们评估了接受医疗性别肯定服务(例如激素、手术)与跨性别青年的 HIV 和其他性传播疾病(STD)预防及知识指标之间的关联。2018 年,我们在美国对 13-24 岁有过性经验的跨性别青年进行了一项在线调查,调查内容包括社会人口统计学、医疗性别肯定以及 HIV 和 STD 预防结果(HIV 检测、STD 检测、暴露前预防(PrEP)知晓情况和非职业暴露后预防(nPEP)知晓情况)。我们使用逻辑回归模型评估了医疗性别肯定与 HIV 和 STD 预防结果之间的关联。交互项和分层模型评估了医疗性别肯定与结果之间关联的差异,这种差异由性别认同决定。参与者的平均年龄为 19.1 岁(标准差=2.7),45%为跨性别女性,29%为跨性别男性,26%为非二进制性别,53%为有色人种青年,19%接受了医疗性别肯定服务。医疗性别肯定与 STD 检测的可能性增加相关(调整后的优势比[aOR] = 1.90;95%置信区间[CI] = 1.33-2.73),但性别认同之间没有显著的交互作用。医疗性别肯定与 PrEP 和 nPEP 知晓情况之间的关联因性别认同而异。在跨性别男性青年中,医疗性别肯定与 PrEP 知晓情况(aOR = 2.65;95% CI = 1.50-4.71)和 nPEP 知晓情况(aOR = 2.03;95% CI = 1.12-3.71)有关。在非二进制青年中,医疗性别肯定与 PrEP 知晓情况相关(aOR = 3.47;95% CI = 1.26-11.27)。医疗性别肯定与性健康服务的使用和知晓情况相关。加强跨性别青年的医疗性别肯定,也可能广泛加强预防保健服务。